Cyrus Bio Featured in US Pharmaceutical Industry Weekly Report

Cyrus Bio CEO, Lucas Nivon, was interviewed by MSA Partners for the October 20, 2017 issue of the US Pharmaceutical Industry Weekly Report. Please contact MSA Partners to subscribe to the newsletter.

About MSA Partners
Founded in 1983, MSA Partners’ mission is to provide Japanese organizations with means and ways to realize and grow their business potential in the US market. As the challenges faced by Japanese organizations doing business in the US have grown increasingly complex over the years, MSA’s integrated and creative approach has become ever more valuable to its clients. MSA takes a team-based approach to combine the skills and expertise of both American and Japanese professionals from MSA, supplement these with outside skills when necessary, and work closely with clients to accomplish their goals. With over 25 years of experience, MSA offers a diverse range of interrelated research, consulting, communications and positioning services, to provide in-depth, comprehensive support to clients. Recognizing that one of the keys to quickly seizing market opportunities is overcoming organizational and language barriers, MSA’s ability to seamlessly interface with our clients at both the head office and US subsidiary level facilitates shared understanding and decision-making.

Cyrus Bio Leads Computational Protein Engineering Panel

SEATTLE, October 17, 2017 — Lucas Nivon, CEO of Cyrus Biotechnology, today will lead a panel on recent advances in computational protein engineering at LabCentral in Cambridge, MA.


Computationally designed therapeutic proteins are in the clinic, and computationally optimized enzymes are producing ingredients of value sustainably and cost effectively. Dr. Nivon will present an overview of published and experimentally verified advances in computational protein engineering, and will demonstrate some modeling workflows with sample software based on the Rosetta protein modeling toolkit first developed at Professor David Baker’s laboratory at the University of Washington. Following Dr. Nivon’s overview, four panelists from Manus Biosynthesis, Moderna Therapeutics, Northeastern University and UMass Dartmouth will present various examples of protein modeling.


In addition to LabCentral, this event has been publicized on Mass Bio and Mass Life Sciences Center web sites.


Click here for registration and full abstracts.